|
🐜
|
Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation.
15 auth.
Sichen Li,
A. Chou,
Weidong Chen,
Ruihuan Chen,
Yuzhong Deng,
H. Phillips,
Julia M. Selfridge,
Mira Zurayk,
Jerry J. Lou,
R. Everson,
...
Kuan Wu,
K. Faull,
T. Cloughesy,
L. Liau,
A. Lai
|
7 |
2013 |
7
🐜
|
|
🐜
|
Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome.
32 auth.
S. Lalezari,
A. Chou,
A. Tran,
O. Solis,
N. Khanlou,
Weidong Chen,
Sichen Li,
J. Carrillo,
Reshmi Chowdhury,
Julia M. Selfridge,
Desiree E. Sanchez,
Ryan W. Wilson,
Mira Zurayk,
Jonathan Lalezari,
Jerry J. Lou,
...
Laurel D Ormiston,
Karen Ancheta,
R. Hanna,
P. Miller,
D. Piccioni,
B. Ellingson,
Colin Buchanan,
P. Mischel,
P. Nghiemphu,
R. Green,
He-jing Wang,
W. Pope,
L. Liau,
R. Elashoff,
T. Cloughesy,
W. Yong,
A. Lai
|
6 |
2013 |
6
🐜
|
|
🐜
|
Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy.
21 auth.
D. Piccioni,
Julia M. Selfridge,
Reema R. Mody,
Reshmi Chowdhury,
Sichen Li,
S. Lalezari,
James Wawrzynski,
Jennifer Quan,
Mira Zurayk,
A. Chou,
...
Desiree E. Sanchez,
L. Liau,
B. Ellingson,
W. Pope,
P. Nghiemphu,
Richard M. Green,
He-Jing Wang,
William H. Yong,
R. Elashoff,
T. Cloughesy,
A. Lai
|
5 |
2014 |
5
🐜
|
|
🐜
|
Risk factors for early return visits to the emergency department in patients with urinary tract infection
7 auth.
S. Jorgensen,
Mira Zurayk,
S. Yeung,
Jill Terry,
Maureen Dunn,
P. Nieberg,
...
A. Wong-Beringer
|
5 |
2018 |
5
🐜
|
|
🐜
|
Emergency Department Urinary Antibiograms Differ by Specific Patient Group
9 auth.
S. Jorgensen,
S. Jorgensen,
Mira Zurayk,
S. Yeung,
Jill Terry,
Maureen Dunn,
...
P. Nieberg,
A. Wong-Beringer,
A. Wong-Beringer
|
4 |
2017 |
4
🐜
|
|
🐜
|
Leveraging Antimicrobial Stewardship in the Emergency Department to Improve the Quality of Urinary Tract Infection Management and Outcomes
8 auth.
S. Jorgensen,
S. Yeung,
Mira Zurayk,
Jill Terry,
Maureen Dunn,
P. Nieberg,
...
J. Pallares,
A. Wong-Beringer
|
4 |
2018 |
4
🐜
|
|
🦁
|
Successful use of uridine triacetate (Vistogard) three weeks after capecitabine in a patient with homozygous dihydropyrimidine dehydrogenase mutation: A case report and review of the literature
Mira Zurayk,
Y. Keung,
David Yu,
E. Hu
|
3 |
2019 |
3
🦁
|
|
🐜
|
Combined analysis of O 6 -methylguani ne-DNA methyltransferase protein expression and promoter methyl ation provides opti mized prognosticati on of gli oblastoma outcome NEURO- ONCOLOGY
31 auth.
S. Lalezari,
A. Chou,
A. Tran,
O. Solis,
N. Khanlou,
Weidong Chen,
Sichen Li,
J. Carrillo,
Reshmi Chowdhury,
Julia M. Selfridge,
Desiree E. Sanchez,
Ryan W. Wilson,
Mira Zurayk,
Jonathan Lalezari,
Laurel D Ormiston,
...
Karen Ancheta,
R. Hanna,
P. Miller,
D. Piccioni,
B. Ellingson,
Colin C. Buchanan,
P. Mischel,
P. Nghiemphu,
R. Green,
He-jing Wang,
W. Pope,
L. Liau,
R. Elashoff,
T. Cloughesy,
W. Yong,
A. Lai
|
0 |
2015 |
0
🐜
|
